Neuracle Technologies, based in Changzhou, China, is a leading company specializing in brain-computer interface (BCI) technologies. Founded in 2011, it focuses on developing equipment such as electroencephalogram (EEG) devices, transcranial electrical stimulation systems, and physiological signal recording tools. These technologies are applied in brain research, medical diagnostics, and treatments for neurological conditions like epilepsy and mental health disorders.

Neuracle is recognized for innovations in both invasive and non-invasive BCI systems, with achievements including high signal-to-noise ratio EEG devices and minimally invasive implants designed for epilepsy monitoring and rehabilitation. Collaborating with top institutions like Tsinghua University, the company also contributes to national R&D projects, enhancing its industry prominence.